Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Clasificación en acciones #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Precio por acción
$7.15
Capitalización bursátil
$313.60M
Cambio (1 día)
-2.12%
Cambio (1 año)
-84.14%
País
DE
Comercio Anbio Biotechnology Class A Ordinary Shares (NNNN)

Categoría

Historial de desdoblamientos de acciones de Anbio Biotechnology Class A Ordinary Shares (NNNN)
La acción Anbio Biotechnology Class A Ordinary Shares (símbolo: NNNN) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Sep 01, 2026.
Una acción NNNN comprada antes de Sep 01, 2026 equivaldría hoy a 0 acciones NNNN.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH